The ability to store the vaccine in warmer temperatures means they can be kept in standard freezers and refrigerators.
Feb. 19, 2021, at 9:20 a.m.
By Alexa Lardieri
PFIZER AND BIONTECH have submitted new data to the Food and Drug Administration showing that their coronavirus vaccine can be stored at higher temperatures, a development that limits logistical challenges posed by transporting and storing a vaccine that until now has required extremely cold storage.
In a press release Friday, Pfizer said the data demonstrates "the stability" of its COVID-19 vaccine when stored at minus 13 degrees to minus 5 degrees Fahrenheit – temperatures more commonly found in freezers and refrigerators in pharmacies.
Vaccine vials would be able to be stored at these temperatures for a total of two weeks "as an alternative or complement to storage in an ultra-low temperature freezer," the release stated.
Pfizer and BioNTech's vaccine is currently labeled as needing to be stored at minus 112 degrees to minus 76 degrees for up to six month
Comment